Sijian Bio
诗健生物
Sijian Bio
Biotech/Healthcare
Shijian Biotech is an innovative antibody developer whose pipeline candidates are positioned as potential global best-in-class or first-in-class therapies. Its pipeline combines drug development viability with commercial potential.
Latest round: Series B (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.